#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2022	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2478	242.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1930	1930	T	287	T	240	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2022	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2478	242.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1664	1664	C	310	C,T	253,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2022	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2478	242.6	0	HET	.	.	.	G642A,C	.	642	642	G	1122	1122	G	328	G,A,C	203,52,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2022	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2478	242.6	0	HET	.	.	.	A69G	.	69	69	A	549	549	A	290	A,G	177,60	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3356	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3914	256.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1863	1863	A	267	A	222	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3356	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3914	256.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2497	2497	C	321	C,A	254,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3356	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3914	256.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2571	2571	A	331	A	266	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3356	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3914	256.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3123	3123	C	282	C	236	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	326	folP	852	852	99.88	folP.l15.c4.ctg.1	1827	53.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	891	893	AAA	73;73;74	A;A,C;A	59;60,2;58	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	326	folP	852	852	99.88	folP.l15.c4.ctg.1	1827	53.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1122	1124	AGC	82;82;81	A;G;C	63;62;63	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	678	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3683	55.1	1	SNP	p	S91F	0	.	.	271	273	TCC	766	768	TCC	56;57;55	T;C;C	46;46;47	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	678	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3683	55.1	1	SNP	p	D95G	0	.	.	283	285	GAC	778	780	GAC	55;55;55	G;A;C	46;46;44	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	678	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3683	55.1	1	SNP	p	D95N	0	.	.	283	285	GAC	778	780	GAC	55;55;55	G;A;C	46;46;44	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	310	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1363	66.9	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	83;84;85	G;G,T;C	67;65,1;66	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	174	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1431	36.3	0	.	n	.	0	A197.	DEL	197	197	A	736	736	A	81	A	67	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	700	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3193	65.6	1	SNP	p	D86N	0	.	.	256	258	GAC	678	680	GAC	80;80;80	G,T;A;C	65,1;60;65	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	700	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3193	65.6	1	SNP	p	S87W	0	.	.	259	261	AGT	681	683	AGT	78;78;77	A,C;G,T;T	61,1;65,1;61	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	700	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3193	65.6	1	SNP	p	S87R	0	.	.	259	261	AGT	681	683	AGT	78;78;77	A,C;G,T;T	61,1;65,1;61	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	700	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3193	65.6	1	SNP	p	S87I	0	.	.	259	261	AGT	681	683	AGT	78;78;77	A,C;G,T;T	61,1;65,1;61	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	700	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3193	65.6	1	SNP	p	S88P	0	.	.	262	264	TCC	684	686	TCC	78;78;78	T;C;C	67;65;66	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	612	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3002	61.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1744	1746	GGC	94;93;93	G;G;C	78;74;75	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1421	1423	GCA	82;84;83	G;C;A	67;69;67	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1424	1426	ATC	83;83;83	A,G;T;C	69,1;67;69	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1436	1438	GTG	82;81;80	G;T;G	68;65;64	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1436	1438	GTG	82;81;80	G;T;G	68;65;64	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1940	1942	ACC	65;65;64	A;C;C	45;46;53	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1994	1996	GCG	62;62;62	G;C;G	50;39;49	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1994	1996	GCG	62;62;62	G;C;G	50;39;49	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2117	2119	GGC	67;67;67	G;G;C	50;53;52	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2126	2128	GGC	67;69;69	G,C;G;C	55,1;57;56	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	580	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2853	60.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2144	2146	CTG	71;72;72	C;T;G	59;57;57	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	744	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3303	67.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1700	1702	CCG	77;77;77	C,G;C;G	61,1;61;60	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	362	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2101	51.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	716	716	C	57	C	46	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	592	594	GAA	96;97;97	G;A;A	74;76;74	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	880	882	GAT	77;76;76	G;A;T	57;57;58	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1003	1005	TCA	73;73;71	T;C;A	60;61;58	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1132	1134	GTC	73;72;71	G;T;C	62;61;60	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1144	1146	TCT	71;72;72	T;C;T	58;60;60	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1462	1464	GCA	75;75;75	G;C;A	61;61;59	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	1	SNP	p	G120K	1	.	.	358	360	AAG	838	840	AAG	81;80;80	A,G;A;G	61,1;61;59	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	1	SNP	p	D121N	0	.	.	361	363	GAC	841	843	GAC	80;80;80	G,T;A;C	63,1;61;61	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	388	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1959	58.9	1	SNP	p	A121D	1	.	.	361	363	GAC	841	843	GAC	80;80;80	G,T;A;C	63,1;61;61	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	1452	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5256	82.7	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2314	2316	AAT	84;83;83	A;A;T	64;66;66	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	212	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1383	46.0	1	SNP	p	V57M	1	.	.	169	171	ATG	693	695	ATG	79;78;79	A;T;G	66;66;67	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
